# Effect of a Pomegranate Extract on Cardiovascular Risk Markers in Overweight Healthy Subjects

> **NCT02061098** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Research Council, Spain** · enrollment: 50 (actual)

## Conditions studied

- Overweight

## Interventions

- **DIETARY_SUPPLEMENT:** Pomegranate extract-first dose-Group A
- **DIETARY_SUPPLEMENT:** Placebo-first dose-Group B
- **DIETARY_SUPPLEMENT:** Pomegranate extract-first dose-Group B
- **DIETARY_SUPPLEMENT:** Placebo-first dose-Group A
- **DIETARY_SUPPLEMENT:** Pomegranate extract-second dose-Group A
- **DIETARY_SUPPLEMENT:** Placebo-second dose-Group B
- **DIETARY_SUPPLEMENT:** Pomegranate extract-second dose-Group B
- **DIETARY_SUPPLEMENT:** Placebo-second dose-Group A

## Key facts

- **NCT ID:** NCT02061098
- **Lead sponsor:** National Research Council, Spain
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-04-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02061098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02061098, "Effect of a Pomegranate Extract on Cardiovascular Risk Markers in Overweight Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02061098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*